Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thromboxane induced red blood cell lysis.

M E Brezinski, D J Lefer, B Bowker

    Prostaglandins
    |January 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Caveolin-1 peptide exerts cardioprotective effects in myocardial ischemia-reperfusion via nitric oxide mechanism.

    American journal of physiology. Heart and circulatory physiology·2001
    Same author

    Elevated ambient glucose induces acute inflammatory events in the microvasculature: effects of insulin.

    American journal of physiology. Endocrinology and metabolism·2001
    Same author

    Pulmonary tissue factor mRNA expression during murine traumatic shock: effect of P-selectin blockade.

    Shock (Augusta, Ga.)·2001
    Same author

    Cardioprotective effects of citrulline in ischemia/reperfusion injury via a non-nitric oxide-mediated mechanism.

    Methods and findings in experimental and clinical pharmacology·2001
    Same author

    Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular disease.

    Cardiovascular research·2001
    Same author

    PR-39, a proline/arginine-rich antimicrobial peptide, exerts cardioprotective effects in myocardial ischemia-reperfusion.

    Cardiovascular research·2000

    Thromboxane A2 mimetics increase red blood cell leakage. This effect is receptor-mediated and concentration-dependent, suggesting a role in cardiovascular disease pathology.

    Area of Science:

    • Biochemistry
    • Cardiovascular Physiology
    • Hematology

    Background:

    • Thromboxane A2 (TxA2) is a potent mediator in cardiovascular physiology.
    • Understanding TxA2's effects on erythrocytes is crucial for cardiovascular disease research.

    Purpose of the Study:

    • To investigate the effect of TxA2 mimetics on erythrocyte membrane integrity.
    • To determine the mechanism and concentration-dependency of TxA2-induced erythrocyte membrane alterations.

    Main Methods:

    • Incubation of feline and human erythrocyte suspensions with TxA2 mimetics (CTA2, U-46619).
    • Assessment of hemoglobin release as an indicator of membrane permeability.
    • Treatment with thromboxane receptor antagonist (BM-13,505) and prostacyclin analog (iloprost).

    Related Experiment Videos

    Main Results:

    • TxA2 mimetics significantly enhanced hemoglobin release from erythrocytes.
    • This effect was attenuated by BM-13,505, indicating receptor mediation.
    • The membrane labilizing effect was concentration-dependent (100-400 ng/ml).
    • Iloprost stabilized erythrocyte membranes, distinguishing the effect from non-specific eicosanoid actions.

    Conclusions:

    • Thromboxane analogs induce erythrocyte membrane leakiness in a receptor-mediated manner.
    • This membrane labilizing action may contribute to the pathophysiology of cardiovascular diseases.
    • TxA2's role in cardiovascular disease may involve direct effects on red blood cell integrity.